| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |